Abstract
Summary
KEY FINDINGS
The Europe dosimeter market is evaluated to grow with a CAGR of 4.84% over the forecast years of 2021 to 2028. Factors such as the robust manufacturing capabilities in the medical diagnostics division, the increasing prevalence of cancer, and the rising awareness associated with the use of dosimeters for radiation monitoring in a radiation-prone environment are expected to supplement the region’s market growth.
MARKET INSIGHTS
The Europe dosimeter market growth analysis includes the assessment of Poland, France, Italy, Germany, Russia, the United Kingdom, Belgium, and the rest of Europe. The nuclear industry in France constitutes the primary market for dosimeters. Moreover, the country harbors 56 operational nuclear power reactors, following the United States, which has 94. As per the World Nuclear Association, France derives more than 71% of its electricity from nuclear energy owing to the favorable policies on the basis of energy security. In addition, France is the largest net exporter of electricity globally, on account of the nation’s relatively low cost of generation, gaining more than EUR 3 billion each year. Dosimetry management plays an essential role in terms of supervising the radiation dose received by workers, especially across controlled areas in nuclear power plants.
On the other hand, Italy has the highest percentage of geriatric population, i.e., people over the age of 65. Besides, the elderly equated to approximately 23% of the country’s total population. Compared to younger individuals, an 11-fold higher incidence of developing cancer is present in the older populace. Furthermore, 70% of all cancer fatalities, as well as 56% of all cancer diagnoses, occur in the over-65 population. Therefore, such factors are accredited to the dosimeters market growth in Europe.
COMPETITIVE INSIGHTS
Some of the top companies operating in the market are Landauer, Miron Technologies, Dosimetrics GmbH, IBA Worldwide, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
1 RESEARCH SCOPE & METHODOLOGY
1.1 STUDY OBJECTIVES
1.2 SCOPE OF STUDY
1.3 METHODOLOGY
1.4 ASSUMPTIONS & LIMITATIONS
2 EXECUTIVE SUMMARY
2.1 MARKET SIZE & ESTIMATES
2.2 MARKET OVERVIEW
3 MARKET DYNAMICS
3.1 KEY DRIVERS
3.1.1 GROWING DEMAND FROM MEDICAL INDUSTRY
3.1.2 CONSISTENT DEMAND FROM NUCLEAR POWER INDUSTRY
3.1.3 INCREASED AWARENESS REGARDING OCCUPATIONAL SAFETY
3.2 KEY RESTRAINTS
3.2.1 LACK OF SKILLED PROFESSIONALS
3.2.2 RISE IN RENEWABLE ENERGY AND PHASING OUT OF NUCLEAR POWER
4 KEY ANALYTICS
4.1 IMPACT OF COVID-19 ON DOSIMETER MARKET
4.2 KEY MARKET TRENDS
4.3 PORTER’S FIVE FORCES ANALYSIS
4.3.1 BUYERS POWER
4.3.2 SUPPLIERS POWER
4.3.3 SUBSTITUTION
4.3.4 NEW ENTRANTS
4.3.5 INDUSTRY RIVALRY
4.4 OPPORTUNITY MATRIX
4.5 VENDOR LANDSCAPE
4.6 KEY BUYING CRITERIA
4.6.1 END-USE
4.6.2 RADIATION TYPE
4.6.3 PASSIVE OR ACTIVE
4.6.4 INFORMATION REQUIRED
4.6.5 LOCATION
4.6.6 RATING
4.6.7 PRICE AND QUALITY
4.7 REGULATORY FRAMEWORK
5 MARKET BY TYPE
5.1 ACTIVE DOSIMETERS
5.2 PASSIVE DOSIMETERS
6 MARKET BY END-USER
6.1 NUCLEAR INDUSTRY
6.2 MEDICAL INDUSTRY
6.3 RESEARCH INSTITUTIONS
6.4 SAFETY & SECURITY INDUSTRY
6.5 HEALTH PHYSICS INDUSTRY
6.6 MINING
7 GEOGRAPHICAL ANALYSIS
7.1 EUROPE
7.1.1 KEY GROWTH ENABLERS
7.1.2 KEY CHALLENGES
7.1.3 KEY PLAYERS
7.1.4 COUNTRY ANALYSIS
- 7.1.4.1 UNITED KINGDOM
- 7.1.4.2 GERMANY
- 7.1.4.3 FRANCE
- 7.1.4.4 ITALY
- 7.1.4.5 RUSSIA
- 7.1.4.6 BELGIUM
- 7.1.4.7 POLAND
- 7.1.4.8 REST OF EUROPE
8 COMPETITIVE LANDSCAPE
8.1 KEY STRATEGIC DEVELOPMENTS
8.1.1 MERGERS & ACQUISITIONS
8.1.2 PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3 PARTNERSHIP & AGREEMENTS
8.1.4 BUSINESS EXPANSIONS & DIVESTITURES
8.2 COMPANY PROFILES
8.2.1 BERTIN INSTRUMENTS
8.2.2 DOSILAB
8.2.3 DOSIMETRICS GMBH
8.2.4 ECOTEST
8.2.5 GAMMADATA INSTRUMENT AB
8.2.6 GE HEALTHCARE
8.2.7 HONEYWELL
8.2.8 IBA WORLDWIDE
8.2.9 LANDAUER
8.2.10 MIRION TECHNOLOGIES
8.2.11 ORTEK (AMETEK)
8.2.12 POLIMASTER
8.2.13 RADIATION DETECTION COMPANY
8.2.14 PTW-FREIBURG GMBH
8.2.15 THERMO FISHER SCIENTIFIC INC